Monoclonal antibodies provide protection against a wide range of infectious microbes, and now, in a series of elegant ...

Abs make up one of the most important classes of advanced biotherapies. GEN interviewed leaders about current challenges and ...

Monoclonal antibodies have been a breakthrough treatment for cancer and other diseases. Now doctors are turning to them in the fight against COVID-19. Find out what this therapy is, how it works ...

Monoclonal antibodies were deemed 'very exciting' early in COVID-19 fight. Since the earliest days of the pandemic, health officials have promised monoclonal antibodies would be a game-changer in ...

Monoclonal antibodies were once the star of COVID-19 outpatient treatments. Since they first became available in 2020 – even before the first vaccines – more than 3.5 million infusions of the ...

Monoclonal antibodies (mAbs) have been a key therapeutic option for non-communicable diseases for decades, and a small number of mAbs have helped treat infectious diseases, including COVID-19.

Monoclonal antibodies can also lower blood cell counts, which can have serious health effects. They include: Low white blood cells, which raises the risk of infections; ...

In this video, Jeremy Faust, MD, editor-in-chief of MedPage Today, looks at the rise and fall of monoclonal antibodies for COVID-19, and discusses the population most affected by the FDA's ...

While common sense may suggest that antibodies that do not neutralize the SARS-CoV-2 virus are of little value, recent studies show they can still confer protection against infection.

Casadevall said new monoclonal antibody drugs are still worth pursuing, since they have proven safe and effective against Covid. “I would not give up on something like this," he said.

Monoclonal antibodies -- treatments developed by cloning a cell that makes an antibody -- could help provide an answer to the growing problem of antimicrobial resistance, say scientists.